RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Showing results 1 to 20 of 119.

Article

A highly G protein-biased mu opioid receptor agonist, sr-17018, has low in vivo efficacy in primates

July 01, 2024
Article

Dopamine D1 receptor in medial prefrontal cortex mediates the effects of TAAR1 activation on chronic stress-induced cognitive and social deficits

July 01, 2024
Article

TAAR1 in dentate gyrus is involved in chronic stress-induced impairments in hippocampal plasticity and cognitive function

June 08, 2024
Article

The imidazoline I2 receptor agonist 2-BFI reduces abuse-related effects of morphine: Self-administration and drug discrimination

March 01, 2024
Article

Effects of a highly G Protein-Biased Mu Opioid Receptor Agonist, SR-17018, in Non-human Primates

June 01, 2023
Article

Isoquinolone derivatives as lysophosphatidic acid receptor 5 (LPA5) antagonists: Investigation of structure-activity relationships, ADME properties and analgesic effects

December 05, 2022
Article

Selective TAAR1 agonists induce conditioned taste aversion

October 01, 2022
Article

In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists

October 01, 2022
Article

TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKIIα activity in the NAc

April 01, 2022
Article

Neuropeptide B/W receptor 1 peptidomimetic agonists: Structure-activity relationships and plasma stability

March 05, 2022
Article

RTICBM-74 Is a brain-penetrant cannabinoid receptor subtype 1 allosteric modulator that reduces alcohol intake in rats

March 01, 2022
Article

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG-018

February 01, 2022
Article

Development of 3-(4-chlorophenyl)-1-(phenethyl)urea analogues as allosteric modulators of the cannabinoid type-1 receptor: RTICBM-189 is brain penetrant and attenuates reinstatement of cocaine-seeking behavior

January 13, 2022
Article

Activation of trace amine-associated receptor 1 attenuates nicotine withdrawal-related effects

January 01, 2022
Article

The selective TAAR1 partial agonist RO5263397 promoted novelty recognition memory in mice

November 01, 2021
Article

Identification of a novel neuropeptide S receptor antagonist scaffold based on the SHA-68 core

October 06, 2021
Article

Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior

July 01, 2021
Article

Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids

July 01, 2021
Article

Discovery of arylsulfonamides as dual orexin receptor agonists

June 24, 2021
Article

Role of trace amine‑associated receptor 1 in the medial prefrontal cortex in chronic social stress-induced cognitive deficits in mice

May 01, 2021